Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Indoor air pollution and neurocognitive disorders in younger and older adults in a marginalized district of Lima, Peru.

Dementia and geriatric cognitive disorders·2026
Same author

Cognitive impairment on the Alzheimer's Disease Centers' Uniform Data Set Version 3 Neuropsychological Test Battery in a Peruvian population with progressive supranuclear palsy.

Arquivos de neuro-psiquiatria·2026
Same author

Redefining the norms: an interdisciplinary perspective on language testing in multilinguals with acquired and progressive neurogenic disorders.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Social vulnerability shapes deep clinical phenotypes and brain health in aging and dementia across Latin America.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Validity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Recommendations for genetic counseling for individuals at risk of autosomal dominant Alzheimer's disease in Latin America.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

関連する実験動画

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

臨床的特徴

Andres Muñoz-Najar1,2, Manuel Montemurro3,4, Maria Del Carmen Tejada3,5

  • 1Universidad Catolica San Pablo, Arequipa, Peru.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ
この要約は機械生成です。

Brain Health Assessment Tablet-Based Cognitive Assessment Tool(BHA-TabCAT)は、アンデス・ペルーの成人において、従来の検査法と比較して認知機能低下の検出において優れた性能を示した。教育や年齢などの要因を組み込むことで、早期の認知障害の特定における精度が向上する。

キーワード:
認知機能低下BHA-TabCATMMSERUDASアンデスペルー高齢者教育年齢

さらに関連する動画

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

関連する実験動画

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学分野:

  • 神経科学
  • 老年学
  • 認知心理学

背景:

  • 特に教育水準が低い、または社会文化的な背景が多様な高齢者における認知機能低下の検出は、大きな課題となっています。
  • 従来の認知評価ツールは、学歴や年齢などの要因を考慮していないため、不正確な診断を提供する可能性があります。
  • BHA-TabCATは、これらの限界に対処するために開発されました。

研究 の 目的:

  • アンデス・ペルーの高齢者集団におけるBHA-TabCATの使用を検証および標準化すること。
  • 既存の認知スクリーニングツールに対するBHA-TabCATの診断パフォーマンスを比較すること。

主な方法:

  • 258人の参加者(54〜91歳)が、BHA-TabCAT、ミニメンタルステート検査(MMSE)、およびローランドユニバーサル(RUDAS)を使用して評価されました。
  • データは、ペルーの田舎(パンパコルカ)と都市(アレキパ)の両方の設定で収集されました。
  • 性別、居住地、年齢、就学年数を共変量として組み込んだ回帰ベースの基準値設定手順が採用されました。

主要な成果:

  • BHA-TabCATは、MMSEおよびRUDASと比較して、認知機能低下の検出において優れた精度を示しました。有意な社会人口統計学的予測因子により、BHA-TabCATは77.4%の曲線下面積(AUC)を達成し、MMSE(66.6%)およびRUDAS(71.9%)を上回りました。教育、年齢、居住地、性別などの共変量を考慮すると、ツールのパフォーマンスが向上しました。

結論:

  • BHA-TabCATは、MMSEおよびRUDASよりもアンデス・ペルーの高齢者における認知機能低下の検出においてより効果的なツールです。
  • 関連する共変量を考慮すると、BHA-TabCATの診断精度が大幅に向上します。
  • この検証されたツールは、多様なペルーの集団における認知機能低下の早期特定のための改善された機会を提供します。